State rests in Ponzi-fraud trial of ex-exec Shkreli in New York

Jul 28, 2017

State rests in Ponzi-fraud trial of ex-exec Shkreli in New York

Closing arguments got underway Thursday in the securities fraud trial of Martin Shkreli, a former hedge fund manager and pharmaceutical executive label "The Most Hated Man in America." The 34-year-old, who hunched over in his chair and fiddled with his hair, risks being jailed for ...

Japan takes aim at ballooning drug prices as costs strain health budget

Feb 8, 2016

Japan takes aim at ballooning drug prices as costs strain health budget

When two of the world's biggest pharmaceutical companies announced a tie-up in Japan, its $78 billion drug industry took note. In November, the nation's largest drugmaker, Takeda Pharmaceutical Co., said it'd separate its off-patent products and share its extensive domestic distribution network with Israel's Teva ...

Takeda gains first foreign chief as Weber is appointed CEO

/ Mar 5, 2015

Takeda gains first foreign chief as Weber is appointed CEO

Takeda Pharmaceutical Co. has named Christophe Weber chief executive officer as part of a planned succession that makes the French national one of the few international executives to lead a Japanese company. Weber, currently the chief operating officer, takes the new position effective April 1, ...

/ Feb 6, 2015

Japanese Ebola drug works: France

The French National Institute of Health and Medical Research said Thursday that clinical trials of the Japanese influenza drug Avigan Tablet, also known as Favipiravir, are showing encouraging results on Ebola patients in Guinea. The office of the French president was informed of the news ...